To date, over 1600 sarcoidosis patients have responded to the survey. Of these, only 31 patients – less than 2%– reported having COVID-19. Most were able to be treated at home and none required mechanical ventilation. Researchers were unable to identify an increased risk associated with race, use of prednisone, or treatment with infliximab (Remicade). Also, the use of hydroxychloroquine (plaquenil) was neither protective nor a risk factor for infection. The study is ongoing and will include a follow up questionnaire in July.
Learn about the conditions that can affect our lungs and access our lung condition specific information.
Learn more about life with a lung condition and things you can do to improve your quality of life.
Learn about the factors that can cause lung disease and the ways to reduce your contact with them.
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.